Abstract
Tumor cells engineered to overexpress molecules that activate an immune response have shown therapeutic promise in preventing growth of cancers. In a new study, tumor cells studded with a ligand-mimicking antibody fragment beckon their own destruction.
Original language | English (US) |
---|---|
Pages (from-to) | 333-334 |
Number of pages | 2 |
Journal | Nature Medicine |
Volume | 8 |
Issue number | 4 |
DOIs | |
State | Published - 2002 |
Externally published | Yes |
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)
- Medicine(all)